News | Artificial Intelligence | April 02, 2020

The web-based services available for free for anyone who wants to use our AI algorithms to analyze a chest X-ray or CT scan

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once

April 2, 2020 — In the face of the COVID-19 pandemic raging around the globe, Vuno has decided to move quickly by joining the global coalition to help address some critical issues facing the international healthcare community today by putting artificial intelligence (AI) into work. A spokesperson said that Vuno has been inundated with requests over the last several weeks regarding how it can help doctors remain resilient and better respond to the spread of the infection and ultimately contribute to saving lives.

In an effort to help the medical community, Vuno has accelerated the development and enhancement of its exiting AI algorithms to better meet the specific needs and demands from exhausted doctors who willingly put themselves at risk to save lives in the fight against COVID-19.

With that mission in mind, the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once. Our one-stop service offering will allow users to choose one or both algorithms to use depending on their own needs by simply visiting one website without the hassle of moving from different AI systems.

The special versions of two AI products for COVID-19 were released this week. These are web-based services available at https://covid19.vunomed.com/ for free for anyone who wants to use theAI algorithms to analyze a chest X-ray or CT scan.

AI Solutions Offered

The common theme of the two AI solutions is to empower healthcare providers to provide better patient care by assisting them in the screening, diagnosis and management of COVID-19 infected patients using our AI technology. They are developed to help protect healthcare providers from burnout or help overworked doctors on the edge of exhaustion in virus fight make a speedier and more accurate diagnostic decision in a difficult time like now. In addition, our cloud-based service offering will enable remote result reading and tracking of the status of patients infected with COVID-19, where radiologists are not readily available.  

In Korea, two local governments in Gangwon Province and a major hospital in Daegu, the hardest-hit area are actively using VUNO Med-Chest X-ray in response to the outbreak. They stated that the instant and visualized results with a colored heatmap from the solution are very helpful to triage patients with suspected infection of the virus, especially when they cannot see the X-ray images clearly due to fogged goggles they have to wear all day long. 

Medical institutions and healthcare providers are encouraged to make the best use of the free online service offering available at https://covid19.vunomed.com/

Related Coronavirus Content:

Two Studies Use SIRD Model to Forecast COVID-19 Spread

Radiology Publishes First Case of COVID-19 Encephalopathy

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Breast Imaging

Aug. 28, 2024 — Rezolut, LLC recently debuted its latest offering for patients during their annual mammogram ...

Time August 29, 2024
arrow
News | Digital Pathology

Paige has launched OmniScreen, an AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 ...

Time August 27, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
News | RSNA

July 31, 2024 — The National Imaging Informatics Course (NIIC), a pioneering program in the radiology field, will return ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
Videos | Information Technology

Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now